טוען...
Symptomatic hypophosphataemia after intravenous iron therapy: an underrated adverse reaction
Iron (ferric carboxymaltose) infusion therapy is used to treat severe iron deficiency which is not responding to the first-line oral iron therapy. However, it can also cause severe renal wasting of phosphate resulting in severe hypophosphataemia in some patients. Despite the growing number of case r...
שמור ב:
| הוצא לאור ב: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Bioscientifica Ltd
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6689119/ https://ncbi.nlm.nih.gov/pubmed/31385673 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-19-0065 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|